stock.name

Exact Sciences Corp.

EXAS

Market Cap$9.99B
Close$

Compare Exact Sciences

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Exact Sciences Corp.Exact Sciences Corp.-48.90%-8%4.10.8
marketMarket Avg54.31.27%32%-1.3
HealthcareHealthcare Avg39.11.36%17%7.21.3
$85.00

Target Price by Analysts

59.4% upsideExact Sciences Target Price DetailsTarget Price
$72.07

Current Fair Value

35.1% upside

Undervalued by 35.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.99 Billion
Enterprise Value$11.71 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.13
Beta1.57
Outstanding Shares184,529,721
Avg 30 Day Volume2,813,160

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-48.95
PEG-100.6
Price to Sales4.1
Price to Book Ratio3.33
Enterprise Value to Revenue4.62
Enterprise Value to EBIT-36.84
Enterprise Value to Net Income-49
Total Debt to Enterprise0.2
Debt to Equity0.76

Revenue Sources

No data

ESG Score

No data

About Exact Sciences Corp.

CEO: Kevin Conroy